The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Tuberculosis is responsible for one in four of all avoidable adult deaths in developing countries. Increased frequency and accelerated fatality of the disease among individuals infected with human immunodeficiency virus has raised worldwide concern that control programmes may be inadequate, and the emergence of multidrug-resistant strains of Mycobacterium tuberculosis has resulted in several recent fatal outbreaks in the United States. Isonicotinic acid hydrazide (isoniazid, INH) forms the core of antituberculosis regimens; however, clinical isolates that are resistant to INH show reduced catalase activity and a relative lack of virulence in guinea-pigs. Here we use mycobacterial genetics to study the molecular basis of INH resistance. A single M. tuberculosis gene, katG, encoding both catalase and peroxidase, restored sensitivity to INH in a resistant mutant of Mycobacterium smegmatis, and conferred INH susceptibility in some strains of Escherichia coli. Deletion of katG from the chromosome was associated with INH resistance in two patient isolates of M. tuberculosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An INH-resistant strain of mc2155 was shown to become sensitive upon expression of the M. tuberculosis catalase-peroxidase gene, katG, suggesting that susceptibility to INH requires the expression of katG (127).”
From Mycobacterium smegmatis: The Vanguard of Mycobacterial Research (2023) · cites this paper as [127]
Citations
Cites
Snapper, S. B., Melton, R. E., Mustafa, S., Kieser, T., & Jr, W. R. J. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb02040.x · Cited by 1,237
Snider, D. E., & Roper, W. L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203053261011 · Cited by 382
Lysogeny and transformation in mycobacteria: stable expression of foreign genes.
Snapper, S. B., Lugosi, L., Jekkel, A., Melton, R. E., Kieser, T., Bloom, B. R., & Jacobs, W. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6987 · Cited by 326
The Biology of the Mycobacteria
Ratledge, C., & Stanford, J. L. (1982) · Cited by 254
Genetic analysis of superoxide dismutase, the 23 kilodalton antigen of Mycobacterium tuberculosis
Zhang, Y., Lathigra, R., Garbe, T., Catty, D., & Young, D. (1991) · Molecular Microbiology · doi:10.1111/j.1365-2958.1991.tb02120.x · Cited by 182
Self-citationWayne, L. G., & Diaz, G. A. (1986) · Analytical Biochemistry · doi:10.1016/0003-2697(86)90200-9 · Cited by 173
Perriëns, J. H., Colebunders, R. L., Karahunga, C., Willame, J.-C., Jeugmans, J., Kaboto, M., Mukadi, Y., Pauwels, P., Ryder, R. W., Prignot, J., et al. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.4.750 · Cited by 162
JACKETT, P. S., ABER, V. R., & LOWRIE, D. B. (1978) · Journal of General Microbiology · doi:10.1099/00221287-104-1-37 · Cited by 162
Nucleotide sequence of katG, encoding catalase HPI of Escherichia coli
Triggs‐Raine, B. L., Doble, B. W., Mulvey, M. R., Sorby, P. A., & Loewen, P. C. (1988) · Journal of Bacteriology · doi:10.1128/jb.170.9.4415-4419.1988 · Cited by 139
Mulvey, M. R., Sorby, P. A., Triggs‐Raine, B. L., & Loewen, P. C. (1988) · Gene · doi:10.1016/0378-1119(88)90498-2 · Cited by 121
Research works printed but not linked: 4
- Murray, C. J. L., Styblo, K. & Rouillon, A. Bull. Int. Union against Tuberculosis and Lung Disorders 65, 6–24 (1990).
- Cohn, M. L., Kovitz, C., Oda, U. & Middlebrook, G. Am. Rev. Tuberc. 70, 641–664 (1954).
- Youatt, J. Am. Rev. respir. Dis. 99, 729–749 (1969).
- Heym, B. & Cole, S. T. Res. Microbiol. (in the press).
Cited by
Items 901–1,000 of 1,000
Laurent, S., Zakham, F., Bertelli, C., Merz, L., Nicod, L. P., Mazza‐Stalder, J., Greub, G., Jaton, K., & Opota, O. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106068 · Cited by 9
Moorey, A. R., Cabanillas, A., Batt, S. M., Ghidelli, S., Urones, B., Sanz, O., Lelièvre, J., Bantscheff, M., Cox, L. R., & Besra, G. S. (2021) · The Cell Surface · doi:10.1016/j.tcsw.2021.100068 · Cited by 8
First principle study of the structure of conjugated amides and thioamides
Velkov, Z., Velkov, Y. Z., Balabanova, E., & Tadjer, A. (2006) · International Journal of Quantum Chemistry · doi:10.1002/qua.21234 · Cited by 8
Rol de la farmacogenómica en el régimen de tratamiento de tuberculosis
Guio, H., Levano, K. S., Sánchez, C., & Tarazona, D. D. (2015) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2015.324.1774 · Cited by 8
Rapid diagnosis of tuberculosis. Detection of drug resistance mechanisms
Viñuelas‐Bayón, J., Vitoria, M. A., & Samper, S. (2017) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2017.08.009 · Cited by 8
Ramírez, L. M. N., Mehaffy, C., & Dobos, K. M. (2018) · InTech eBooks · doi:10.5772/intechopen.69594 · Cited by 8
Vilchèze, C., & Jacobs, W. R. (2015) · ASM Press eBooks · doi:10.1128/9781555818845.ch22 · Cited by 14
Detection and purification of a catalase-peroxidase from Mycobacterium sp. Pyr-1
Rafii, F., Lunsford, P., Hehman, G. L., & Cerniglia, C. E. (1999) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1999.tb13515.x · Cited by 8
Presence of katG gene in resistant Mycobacterium tuberculosis.
Jaber, M. T., Rattan, A., & Kumar, R. P. (1996) · Journal of Clinical Pathology · doi:10.1136/jcp.49.11.945 · Cited by 8
Marks, G. L. (1993) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30189-4 · Cited by 9
The Emerging Landscape of Tubercular Targets: A Medicinal Chemistry Approach
Shaik, B. B., Moodley, K., Ghumran, S., Bala, M. D., Singh, P., & Karpoormath, R. V. (2025) · Medicinal Research Reviews · doi:10.1002/med.22100 · Cited by 8
Thwe, E. P., Namwat, W., Pinlaor, P., Rueangsak, K., & Sangka, A. (2021) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-021-03163-7 · Cited by 7
Isoniazid Derivatives as Anti-Tubercular Agents: From Structural Design to Clinical Investigations
Nongkhlaw, R., Nongkhlaw, R., & Bisht, R. (2022) · Infectious Disorders - Drug Targets · doi:10.2174/1871526522666221004152324 · Cited by 7
Chang, K. C., Yew, W., & Zhang, Y. (2009) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530050802665694 · Cited by 8
Self-citationPrakash, R., Gupta, R., Katoch, V. M., & Tiwari, P. K. (2017) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2017.01.005 · Cited by 7
Isa, M. A., & Majumdar, R. S. (2019) · Journal of Proteins and Proteomics · doi:10.1007/s42485-019-00006-w · Cited by 7
Xiong, Y., Wei, J., Cai, Y., Zhang, Y., Feng, L., & Zhang, Y. (2022) · BioMed Research International · doi:10.1155/2022/9542756 · Cited by 9
Self-citationEffects of benzothiazinone and ethambutol on the integrity of the corynebacterial cell envelope
Meyer, F. M., Repnik, U., Karnaukhova, E., Schubert, K., & Bramkamp, M. (2023) · The Cell Surface · doi:10.1016/j.tcsw.2023.100116 · Cited by 8
Núñez, M. C., Menendez, M. C., Rebollo, M. J., & García, M. J. (2008) · BMC Microbiology · doi:10.1186/1471-2180-8-100 · Cited by 7
Martinez-Rojas, E., Kurt, T., Schmidt, U., Meyer, V., & Garbe, L. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-5808-2 · Cited by 7
Kamachi, S., Hirabayashi, K., Tamoi, M., Shigeoka, S., Tada, T., & Wada, K. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.11.037 · Cited by 7
Role of Plant Secondary Metabolites in Metabolic Disorders
Hajam, Y. A., Rani, R., Sharma, P., Khan, I. A., & Kumar, R. (2022) · Springer eBooks · doi:10.1007/978-981-16-4779-6_8 · Cited by 10
Transport and utilization of rhizoferrin bound iron in Mycobacterium smegmatis
Matzanke, B. F., Böhnke, R., Möllmann, U., Schünemann, V., SCHUMANN, G., TRAUTWEIN, A. X., & Winkelmann, G. (1999) · BioMetals · doi:10.1023/a:1009274415607 · Cited by 7
Hallenbeck, P. L., Minucci, S., Lippoldt, R. E., Phyillaier, M., Horn, V. J., Ozato, K., & Nikodem, V. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10503 · Cited by 7
Böttger, E. C. (2011) · Progress in respiratory research/Progress in research in emphysema and chronic bronchitis/Progress in respiration research · doi:10.1159/000324630 · Cited by 7
Tuberculosis: Beating the bacillus
Young, D. B. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00077-4 · Cited by 7
Self-citationCarpena, X., Guarné, A., Ferrer, J. C., Alzari, P. M., Fita, I., & Loewen, P. C. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902004201 · Cited by 7
Mycobacterial virulence factors.
Gordon, S. V., & Andrew, P. W. (1996) · PubMed · Cited by 7
Zhang, Y., & Jacobs, W. R. (2008) · Wiley eBooks · doi:10.1002/9783527611614.ch15 · Cited by 16
Self-citationFriedland, J. S. (1997) · Nature · doi:10.1038/387226a0 · Cited by 7
Johnson, R. (2007) · SUNScholar (Stellenbosch University) · Cited by 10
Aldrich, C. C., Boshoff, H. I., & Remmel, R. P. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc231 · Cited by 7
Vaccines against Intracellular Pathogens
Barletta, R. G., Donis, R. O., Chacón, O., Shams, H., & Cirillo, J. D. (2000) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4757-4580-1_22 · Cited by 7
Integration of multi-modal measurements identifies critical mechanisms of tuberculosis drug action
Johnson, W. C., Alivisatos, A. P., Smith, T. C., Van, N., Soni, V., Wallach, J. B., Clark, N. A., Fitzgerald, T. A., Whiteley, J. J., Tan, S., et al. (2025) · Cell Systems · doi:10.1016/j.cels.2025.101348 · Cited by 8
Bleiblo, F. A., El-Awamie, M. W. M., Elsharif, N. A., Feetouri, M. M., Alogali, I. S., Mohamed, A. A. I., Aloriby, M. A., Salabi, A. A. E., Bader, T. S., Moftah, S. A. M., et al. (2026) · Antibiotics · doi:10.3390/antibiotics15010092 · Cited by 9
Tailoring selective triclosan azo-adducts: Design, synthesis, and anti-mycobacterial evaluation
Shekhar, Alcaraz, M., Seboletswe, P., Manhas, N., Kremer, L., Singh, P., & Kumar, V. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22182 · Cited by 6
Patel, V. P., Tripathi, R. K. P., & Mandal, S. D. (2024) · Current Computer - Aided Drug Design · doi:10.2174/0115734099353857241022102426 · Cited by 6
Kamsri, P., Punkvang, A., Hannongbua, S., Saparpakorn, P., & Pungpo, P. (2015) · RSC Advances · doi:10.1039/c5ra08103c · Cited by 6
The Evolution of Antibiotic Resistance
Gónzález‐Candelas, F., Comas, I., Martínez, J. L., Galán, J. C., & Baquero, F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-799942-5.00012-3 · Cited by 9
Anti-Mycobacterial Peroxides: A New Class of Agents for Development Against Tuberculosis
van der Westhuyzen, C. W., Haynes, R. K., Panayides, J., Wiid, I. J. F., & Parkinson, C. J. (2019) · Medicinal Chemistry · doi:10.2174/1573406415666190430143535 · Cited by 6
Differential Isoniazid Response Pattern Between Active and Dormant Mycobacterium tuberculosis
Abo-Kadoum, M. A., Dai, Y., Asaad, M., Hamdi, I., & Xie, J. (2020) · Microbial Drug Resistance · doi:10.1089/mdr.2020.0179 · Cited by 6
Yam, W.-C., & Siu, G. G. (2012) · Methods in molecular biology · doi:10.1007/978-1-60327-353-4_12 · Cited by 6
Kamsri, P., Punkvang, A., Saparpakorn, P., Hannongbua, S., Irle, S., & Pungpo, P. (2014) · Journal of Molecular Modeling · doi:10.1007/s00894-014-2319-0 · Cited by 6
Multidrug-resistant tuberculosis
Jacobs, R. F. (1996) · Seminars in Pediatric Infectious Diseases · doi:10.1016/s1045-1870(96)80005-7 · Cited by 6
Sun, Y., Li, S., Zhou, L., Zhou, L., Zhong, Q., Fang, S., Chen, T., Bi, L., Mat, W., Zhao, C., et al. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-5356-1 · Cited by 6
The chemotherapy of tuberculosis — from the past to the future
Collazos, J., Mayo, J., & Martínez, E. (1995) · Respiratory Medicine · doi:10.1016/0954-6111(95)90121-3 · Cited by 6
The Significance of Flavonoids as a Potential Anti-TuberculosisCompounds
Aşkun, T. (2015) · Research and reviews : journal of pharmacology and toxicological studies · Cited by 9
Drug Resistant Mycobacterium tuberculosis and New Drug Development
Patel, D. M., Patel, S. D., Jaiswal, P. S., & Brahmbhatt, K. J. (2012) · International Journal of Drug Development and Research · Cited by 6
rpoBgene mutations amongMycobacterium tuberculosisisolates from extrapulmonary sites
Khosravi, A. D., Meghdadi, H., Ghadiri, A., Alami, A., Sina, A. H., & Mirsaeidi, M. S. (2018) · Apmis · doi:10.1111/apm.12804 · Cited by 6
Biodistribution of Tc-99m Labeled Isoniazid Solid Lipid Nanoparticles in Wistar Rats.
Ghazizadeh, F., Ghaffari, S., Mirshojaei, S. F., Mazidid, M., & Azarmi, S. (2018) · PubMed Central · Cited by 6
Lu, N., Yang, Y., Liu, J., Li, J., Ouyang, B., Xia, J., & Du, Y. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.103971 · Cited by 6
Dielectrophoretic characterization of antibiotic-treated Mycobacterium tuberculosis complex cells
Inoue, S., Lee, H.-B., Becker, A. L., Weigel, K. M., Kim, J., Lee, K.-H., Cangelosi, G. A., & Chung, J.-H. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-8928-3 · Cited by 8
Synthesis and biological activity of alkynoic acids derivatives against mycobacteria
Vilchèze, C., Leung, L. W., Bittman, R., & Jacobs, W. R. (2015) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2015.08.001 · Cited by 6
The Proteome of Mycobacterium tuberculosis
Belisle, J. T., Braunstein, M., Rosenkrands, I., & Andersen, P. L. (2004) · Wiley eBooks · doi:10.1128/9781555817657.ch16 · Cited by 6
Treatment and developmental therapeutics of Mycobacterium tuberculosis infections
Georgiev, V. S. (1994) · International Journal of Antimicrobial Agents · doi:10.1016/0924-8579(94)90005-1 · Cited by 6
Mutations of katG and inhA in MDR M. tuberculosis
Lin, H. H., Kim, H.-Y., Yun, Y.-J., Park, C. G., Kim, B., Park, Y.-G., & Kook, Y. (2007) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2007.63.2.128 · Cited by 6
Osoba, A. O. (2004) · Springer eBooks · doi:10.1007/978-3-642-18937-1_8 · Cited by 6
RECENT ADVANCES IN TUBERCULOSIS DIAGNOSTIC TECHNIQUES
MENON, P., Kapila, K., & Ohri, V. C. (2000) · Medical Journal Armed Forces India · doi:10.1016/s0377-1237(17)30131-4 · Cited by 6
[Detection of rifampin-resistant Mycobacterium tuberculosis by line probe assay (LiPA)].
Abe, C., Ogata, H., Kawata, K., Hiraga, T., Takashima, T., & Suetake, T. (2000) · PubMed · Cited by 6
Antibiotics and New Inhibitors of the Cell Wall
Dover, L. G., Alderwick, L. J., Bhowruth, V., Brown, A. K., Kremer, L., & Besra, G. S. (2014) · ASM Press eBooks · doi:10.1128/9781555815783.ch7 · Cited by 6
Morris, S. L., & Rouse, D. A. (1996) · Research in Microbiology · doi:10.1016/0923-2508(96)80206-3 · Cited by 6
Differentially Expressed Genes of Mycobacterium tuberculosis
Marston, B. J., & Shinnick, T. M. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb52947.x · Cited by 6
Risk‑Based Prediction of Novel AMR Variants Using Protein Language ModelsPreprint
Wood, J. J., Portelli, S., Ascher, D. B., & Furnham, N. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.12.672331 · Cited by 6
Drug Resistance in Tuberculosis: Nanomedicines at Rescue
Kumar, N., Das, B., & Patra, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-52733-0.00010-0 · Cited by 5
Antibacterial Agent‐Loaded Hydrogels for Implant‐Associated Osteomyelitis: A Review
Ji, B., Zhang, L., Xiao, L., Guo, Z., & Liu, Z. (2025) · Macromolecular Bioscience · doi:10.1002/mabi.202500528 · Cited by 5
Towards zero excess sludge discharge with built-in ozonation for wastewater biological treatment
Wan, C., Huang, S., Li, M., Zhang, L., Yuan, Y., Zhao, X., & Wu, C. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.171798 · Cited by 5
Wang, Y., & Goodwin, D. C. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.08.003 · Cited by 5
Zhou, A., Nawaz, M., Duan, Y., Moore, J. E., Millar, B. C., Xu, J., & Yao, Y. (2011) · Microbial Drug Resistance · doi:10.1089/mdr.2010.0135 · Cited by 5
Catalase-peroxidase (KatG) Structure and Function
Fita, I., Carpena, X., & Loewen, P. C. (2015) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622628-00133 · Cited by 5
Nachappa, S. A., Neelambike, S. M., & Ramachandra, N. B. (2022) · Tuberculosis · doi:10.1016/j.tube.2022.102201 · Cited by 5
Evolution ofMycobacterium tuberculosis: New Insights into Pathogenicity and Drug Resistance
Boritsch, E. C., & Brosch, R. (2017) · ASM Press eBooks · doi:10.1128/9781555819569.ch22 · Cited by 5
Tuberculosis: laboratory diagnosis and treatment strategies
McHugh, T. D. (2013) · CABI eBooks · doi:10.1079/9781845938079.0000 · Cited by 5
Unissa, A. N., Narayanan, S., Suganthi, C., & Selvakumar, N. (2011) · International journal of molecular and clinical microbiology · Cited by 5
Mechanisms of Action and Resistance of the Antimycobacterial Agents
Dutta, N. K., & Karakousis, P. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-46718-4_25 · Cited by 5
Tuberculosis - Present Medication and Therapeutic Prospects
Jelińska, A., Zając, M., Dadej, A., Tomczak, S., Geszke-Moritz, M., & Muszalska-Kolos, I. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666181120100025 · Cited by 6
Tenover, F. C., & Rasheed, J. K. (2011) · Molecular Microbiology · doi:10.1128/9781555816834.ch32 · Cited by 6
Antimycobacterial activity and in silico study of highly functionalised dispiropyrrolidines
Wei, A. C., Ali, M. A., Yeong, K. Y., Choi, S. B., Osman, H., Masand, V. H., & Choon, T. S. (2014) · Medicinal Chemistry Research · doi:10.1007/s00044-014-1181-z · Cited by 5
Insights into the pharmacokinetic properties of antitubercular drugs
Shukla, M. K., Sharma, A., Jaiswal, S., & Lal, J. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2016.1183643 · Cited by 5
Shanthi, V., & Ramanathan, K. (2013) · 3 Biotech · doi:10.1007/s13205-013-0146-0 · Cited by 7
Detection of rifampin-resistant bacteria using DNA probes for precursor rRNA
Britschgi, T. B., & Cangelosi, G. A. (1995) · Molecular and Cellular Probes · doi:10.1016/s0890-8508(95)90932-x · Cited by 5
Amplification reactions in mycobacteriology
Klatser, P. R. (1995) · Journal of Microbiological Methods · doi:10.1016/0167-7012(95)00034-i · Cited by 7
Wallace, R. E., & Josephy, P. D. (1994) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(94)90068-x · Cited by 5
Ohno, H., Koga, H., Kohno, S., Higashiyama, Y., Miyazaki, Y., OgawaK, Yanagihara, K., Yamamoto, Y., Noda, T., & Miyamoto, J. (1994) · PubMed · Cited by 5
Frantom, P. A., & Blanchard, J. S. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00679-1 · Cited by 5
Tuberculosis and other mycobacterial infections
Ormerod, L. P. (2010) · Elsevier eBooks · doi:10.1016/b978-0-7020-4064-1.00058-0 · Cited by 5
Drug Resistant and Persistent Tuberculosis: Mechanisms and Drug Development
Zhang, Y. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1400-1_22 · Cited by 5
Self-citationEpidemiology of multidrug-resistant tuberculosis in low- and middle-income countries
Espinal, M. (2000) · Resurgent and emerging infectious diseases · doi:10.1007/978-94-011-4084-3_3 · Cited by 6
Zhang, Y. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)30030-9 · Cited by 5
Self-citationUsing molecular methods to detect antimicrobial resistance genes
Tenover, F. C., Popović, T., & Olsvik, Ø. (1993) · Clinical Microbiology Newsletter · doi:10.1016/0196-4399(93)90009-c · Cited by 5
The molecular basis of mycobacterial infection
Colston, M. J. (1996) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(96)00002-7 · Cited by 7
Cabot, R. C., Scully, R. E., Mark, E. J., McNeely, W. F., McNeely, B. U., Basgoz, N. O., & Mattia, A. R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300408 · Cited by 7
Zaheer, I. E., Rehman, S. U., Liaquat, M., Saif, M., Kanval, F., Jehan, S., Ali, S., Alasmari, A., Alomrani, S. O., Al-Ashkar, I. M., et al. (2026) · Scientific Reports · doi:10.1038/s41598-025-34464-8 · Cited by 4
Identification of new drug targets in Mycobacterium avium and Mycobacterium tuberculosis
Rastogi, N., Goh, K. S., Ginkel, S. Z.-V., Wright, E. L., & Barrow, W. W. (1996) · Research in Microbiology · doi:10.1016/0923-2508(96)80210-5 · Cited by 4
Current Status of Anti-Tuberculosis Therapy: A Patent Analysis
Singh, A., Budhraj, A., Shrivastava, A., Satyavana, A., Gupta, A., Gupta, M., Wadhwa, G., Sharma, S., & Jain, C. K. (2014) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/1574891x09666140711111800 · Cited by 4
Tuberculosis multidrogorresistente
Aristizabal, C. (2020) · Revista Salud Bosque · doi:10.18270/rsb.v10i1.2834 · Cited by 4
Fan, X., Zhao, B., Zhang, W., Li, N., Mi, K., & Wang, B. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.05367-22 · Cited by 4
Tuberculosis: introduction, drug regimens, and multidrug-resistance
Singh, S., Dhankar, N., Garg, A. K., Molugulu, N., & Kesharwani, P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819811-7.00002-3 · Cited by 10
Vilchèze, C., Saranathan, R., Weinrick, B. C., & Jacobs, W. R. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00792-20 · Cited by 4
Liu, F., Hu, J., Chang, L., & Jiang, Y. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104466 · Cited by 4
Ok, V., Aubry, A., Morel, F., Bonnet, I., Robert, J., & Sougakoff, W. (2021) · Antibiotics · doi:10.3390/antibiotics10070797 · Cited by 4
Metadata
- Authors
- Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S.
- Affiliations
- Hammersmith Hospital (GB)
- Institut Pasteur (FR)
- Venue
- Nature
- Published
- 1992-08-13
- Volume
- 358
- Issue
- 6387
- Pages
- 591-593
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2058925610
- Cited by
- 1,299
- References
- 17
- Citations by year
- 2026: 21 · 2025: 27 · 2024: 28 · 2023: 26 · 2022: 35 · 2021: 34 · 2020: 47 · 2019: 45 · 2018: 49 · 2017: 50 · 2016: 36 · 2015: 47 · 2014: 69 · 2013: 37 · 2012: 50
- FWCI
- 37.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Keywords
- isoniazid resistance, Mycobacterium tuberculosis, katG gene, catalase-peroxidase, multidrug resistance, Mycobacterium smegmatis, Escherichia coli, gene deletion, antitubercular agents, tuberculosis
- MeSH terms
- Amino Acid Sequence, Bacterial Proteins, Base Sequence, Catalase, Cloning, Molecular, DNA, Bacterial, Drug Resistance, Microbial, Escherichia coli, Genes, Bacterial, Isoniazid, Molecular Sequence Data, Mutation, Mycobacterium tuberculosis, Peroxidases, Plasmids, Blotting, Southern, Restriction Mapping, Oligonucleotide Probes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.